UK–Singapore Regulatory Innovation Corridor Launched: MHRA, HSA and Flagship Pioneering Aim to Speed Breakthrough Health Technologies
London/Singapore — December 13, 2025 — UK and Singapore health regulators have unveiled a new cross-border “Regulatory Innovation Corridor” designed to help developers move breakthrough medicines, medical technologies and advanced diagnostics to patients faster—without lowering safety standards. The initiative, announced on Friday (December 12), links the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) with Singapore’s Health Sciences Authority (HSA) and begins with biotech creator Flagship Pioneering as the first industry partner. GOV.UK+1 The corridor is being positioned as a practical fix for a common bottleneck in modern healthcare innovation: when one product must satisfy multiple regulators, companies often repeat